MedPath
NMPA Approval

Telmisartan and Amlodipine Tablets (Ⅱ)

国药准字H20253588

March 11, 2025

Drug Information

替米沙坦氨氯地平片(Ⅱ)

片剂

每片含替米沙坦40mg与苯磺酸氨氯地平5mg(按氨氯地平计)

化学药品

March 11, 2025

Company Information

Applicant Company

北京市海淀区阜石路69号碧桐园1号楼4层

Manufacturing Company

北京市大兴区中关村科技园区大兴生物医药产业基地华佗路32号院

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替米沙坦氨氯地平片(Ⅱ) - NMPA 批准文号 | MedPath